Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141009019470N74Phase 3Completed
Phase 3 trial of lidocaine in cough, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Incidence of cough after fentanyl injection. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141009019470N74.